Header cover image

U.K. (FTSE) Life Sciences Industry Analysis

UpdatedNov 28, 2022
DataAggregated Company Financials
Companies12
  • 7D-1.4%
  • 3M-2.8%
  • 1Y-50.7%
  • YTD-53.2%

Over the last 7 days, the Life Sciences industry has dropped 1.4%, driven by MaxCyte declining 7.2%. Meanwhile, hVIVO actually outperformed within the industry, gaining 9.0% in the last week. The industry has fallen 51% in the last year. Looking forward, earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the U.K. Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 28 Nov 2022UK£3.6bUK£446.7m-UK£179,083,272.0048.9x-20x8x
Wed, 26 Oct 2022UK£3.6bUK£448.4m-UK£176,145,908.0044.1x-20.2x7.9x
Fri, 23 Sep 2022UK£3.6bUK£430.4m-UK£176,981,485.0044.9x-20.2x8.3x
Sun, 21 Aug 2022UK£4.0bUK£369.5m-UK£191,630,387.0050.3x-21x10.9x
Tue, 19 Jul 2022UK£3.5bUK£367.2m-UK£188,315,171.0038.1x-18.8x9.6x
Thu, 16 Jun 2022UK£3.9bUK£364.3m-UK£189,706,589.0038.4x-20.4x10.6x
Sat, 14 May 2022UK£3.6bUK£362.0m-UK£191,849,667.0039.9x-18.5x9.8x
Mon, 11 Apr 2022UK£6.4bUK£930.0m-UK£312,873,925.0049x-20.6x6.9x
Wed, 09 Mar 2022UK£6.1bUK£892.0m-UK£202,922,339.0043.5x-30.1x6.8x
Fri, 04 Feb 2022UK£7.5bUK£848.7m-UK£185,200,987.0030.6x-40.4x8.8x
Sun, 02 Jan 2022UK£9.8bUK£849.0m-UK£184,734,302.0030.8x-53.2x11.6x
Tue, 30 Nov 2021UK£8.8bUK£844.1m-UK£191,247,190.0020.1x-46.2x10.5x
Thu, 28 Oct 2021UK£7.5bUK£819.7m-UK£188,749,748.0026.1x-39.8x9.2x
Sat, 25 Sep 2021UK£3.1bUK£690.4m-UK£130,318,119.0029.8x-23.6x4.5x
Mon, 23 Aug 2021UK£2.9bUK£670.4m-UK£160,499,800.3564.5x-18.2x4.4x
Sat, 10 Jul 2021UK£3.0bUK£670.4m-UK£160,499,800.3561.5x-18.6x4.5x
Fri, 02 Apr 2021UK£3.4bUK£670.8m-UK£88,500,847.0870.2x-38.8x5.1x
Mon, 04 Jan 2021UK£3.2bUK£671.0m-UK£14,838,270.6069.6x-212.8x4.7x
Thu, 08 Oct 2020UK£2.6bUK£652.1mUK£164.9m48x15.6x3.9x
Wed, 01 Jul 2020UK£2.4bUK£632.0mUK£377.7m39.7x6.4x3.8x
Sat, 04 Apr 2020UK£1.9bUK£617.1mUK£355.9m38.9x5.2x3x
Tue, 07 Jan 2020UK£2.6bUK£601.7mUK£316.1m75.5x8.3x4.3x
Price to Earnings Ratio

13.2x


Total Market Cap: UK£2.4bTotal Earnings: UK£180.1mTotal Revenue: UK£581.5mTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Life Sciences Industry Price to Earnings3Y Average -34.2x202020212022
Current Industry PE
  • Investors are relatively neutral on the British Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 7.3x.
Past Earnings Growth
  • Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 8.4% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market1.33%
Healthcare0.72%
Life Sciences-1.42%
Clinical Research and Equipment-1.42%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HVO hVIVOUK£0.139.0%
+UK£7.0m
-34.6%PS2.5x
ONT Oxford Nanopore TechnologiesUK£2.580.2%
+UK£4.1m
-60.0%PS10.8x
C4XD C4X Discovery HoldingsUK£0.200.7%
+UK£378.2k
-52.6%PS9.1x
IXI IXICOUK£0.291.8%
+UK£240.8k
-45.8%PE14.7x
PRM Proteome SciencesUK£0.0381.3%
+UK£147.6k
-30.9%PE20.1x
Simply Wall St™
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GDR

UK£0.09

genedrive

7D

-29.4%

1Y

-61.2%

ERGO

UK£13.02

Ergomed

7D

-2.4%

1Y

-2.1%

PRM

UK£0.038

Proteome Sciences

7D

1.3%

1Y

-30.9%

ONT

UK£2.58

Oxford Nanopore Technologies

7D

0.2%

1Y

-60.0%

OBD

UK£0.20

Oxford BioDynamics

7D

-9.5%

1Y

-52.6%

IXI

UK£0.29

IXICO

7D

1.8%

1Y

-45.8%

HVO

UK£0.13

hVIVO

7D

9.0%

1Y

-34.6%

C4XD

UK£0.20

C4X Discovery Holdings

7D

0.7%

1Y

-52.6%